In this article, we will discuss Mesna and Postmarketing Experience. So, let’s get started.
Postmarketing Experience
The following adverse reactions have been reported in the postmarketing experience of patients receiving Mesna in combination with ifosfamide or similar drugs, making it difficult to distinguish the adverse reactions which may be due to Mesna from those caused by the concomitantly administered cytotoxic agents. Because these reactions are reported from a population of unknown size, precise estimates of frequency
cannot be made.
Cardiovascular: Hypertension
Gastrointestinal: Dysgeusia
Hepatobiliary: Hepatitis
Nervous System: Convulsion
Respiratory: Hemoptysis